Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Structural and proteomic analysis of the mouse cathepsin B-DARPin 4m3 complex reveals species-specific binding determinants
Authors:ID Zarić, Miki, Institut "Jožef Stefan" (Author)
ID Tušar, Livija, Institut "Jožef Stefan" (Author)
ID Kramer, Lovro, Institut "Jožef Stefan" (Author)
ID Vasiljeva, Olga, Institut "Jožef Stefan" (Author)
ID Novak, Matej, Institut "Jožef Stefan" (Author)
ID Impens, Francis (Author)
ID Usenik, Aleksandra, Institut "Jožef Stefan" (Author)
ID Gevaert, Kris (Author)
ID Turk, Dušan, Institut "Jožef Stefan" (Author)
ID Turk, Boris, Institut "Jožef Stefan" (Author)
Files:URL URL - Source URL, visit https://www.wwpdb.org/pdb?id=pdb_00009s60
 
URL URL - Source URL, visit https://www.mdpi.com/1422-0067/26/24/11910
 
.pdf PDF - Presentation file, download (5,66 MB)
MD5: D895CB9BBADEC9746BEEC00BA4606EC1
Description: Povezava do raziskovalnih podatkov: https://doi.org/10.2210/pdb9S60/pdb.
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Cathepsin B (CatB) is a lysosomal cysteine protease that plays a major role in various pathologies and is therefore considered a valuable therapeutic target. To address species-specific inhibitor challenges, we characterized the selective binding of designed ankyrin repeat protein (DARPin) 4m3 toward mouse cathepsin B (mCatB) over human CatB (hCatB). The mCatB–DARPin 4m3 complex was validated by size-exclusion chromatography (SEC), nano-differential scanning fluorimetry (nano-DSF), and surface plasmon resonance (SPR), revealing high affinity binding (KD = 65.7 nM) and potent inhibition (Ki = 26.7 nM; mixed competitive/noncompetitive). DARPin 4m3 showed no binding/inhibition toward hCatB. The 1.67 Å crystal structure of the complex—the first for mCatB—identified key interaction residues (e.g., I65/Q66 in mCatB vs. S65/M66 in hCatB) conferring selectivity. Proteomic analysis of endogenous substrates using a support vector machine (SVM) revealed greater similarity between mCatB and hCatB cleavages (Area Under the Curve (AUC) = 0.733) than between mCatB and other human cathepsins (AUC = 0.939–0.965). Clustering and SVM methods offer broadly applicable tools for protease specificity profiling in drug discovery. This study demonstrates the utility of DARPins for species-selective targeting and highlights the importance of integrated structural and proteomic approaches for dissecting protein–protein interactions.
Keywords:cathepsin B, protein inhibitor, proteomics
Publication status:Published
Publication version:Version of Record
Submitted for review:16.10.2025
Article acceptance date:04.12.2025
Publication date:10.12.2025
Publisher:MDPI
Year of publishing:2025
Number of pages:str. 1-37
Numbering:Vol. 26, iss. 24, [article no.] 11910
Source:Švica
PID:20.500.12556/DiRROS-25322 New window
UDC:577
ISSN on article:1422-0067
DOI:10.3390/ijms262411910 New window
COBISS.SI-ID:264865795 New window
Copyright:© 2025 by the authors.
Note:Nasl. z nasl. zaslona; Soavtorji iz Slovenije: Livija Tušar, Lovro Kramer, Olga Vasiljeva, Matej Novak, Aleksandra Usenik, Dušan Turk, Boris Turk; Opis vira z dne 15. 1. 2026;
Publication date in DiRROS:16.01.2026
Views:115
Downloads:101
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0140-2022
Name:Proteoliza in njena regulacija pri zdravju in boleznih

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0048-2018
Name:Strukturna biologija

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:10.12.2025
Applies to:VoR

Secondary language

Language:Slovenian
Keywords:katepsin B, proteomika, zaviralci


Back